wire - news in brief




Page not found (Error 404)




Life Sciences - Oct 22
Life Sciences
A new neural recording technique developed by EPFL bioengineers enables for the first time the comprehensive measurement of neural circuits that control limb movement. Tested on the fruit fly, results from the technique may inspire the development of more sophisticated robotic control approaches. One of the major goals of biology, medicine, and robotics is to understand how limbs are controlled by circuits of neurons working together.
Life Sciences - Oct 22
Life Sciences

Even though the water we've used for washing our hands is barely contaminated, it usually disappears down the drain, never to be used again.

Environment - Oct 18
Environment

According to the prevailing opinion, species-rich ecosystems are more stable against environmental disruptions such as drought, hot spells or pesticides.


Category



Results 1 - 50 of 318.
1 2 3 4 5 7 Next »


Medicine / Pharmacology - 22.10.2018
Roche’s Tecentriq plus chemotherapy (carboplatin and Abraxane) as an initial treatment helped people with advanced non-squamous non-small cell lung cancer live significantly longer compared to chemotherapy alone
Unsere Webseite verwendet Cookies, um Ihnen einen optimalen Service zu bieten. Durch die Nutzung dieser Webseite erklären Sie sich damit einverstanden.

Medicine / Pharmacology - Life Sciences - 21.10.2018
Roche’s investigational personalised medicine entrectinib shrank tumours in people with NTRK fusion-positive solid tumours
Unsere Webseite verwendet Cookies, um Ihnen einen optimalen Service zu bieten. Durch die Nutzung dieser Webseite erklären Sie sich damit einverstanden.

Medicine / Pharmacology - Life Sciences - 19.10.2018
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping mutated non-small cell lung cancer (NSCLC)   Clinical findings from ongoing study indicate safety prof

Medicine / Pharmacology - 19.10.2018
Novartis announces presentation of new Lutathera NETTER-1 data
Novartis announces presentation of new Lutathera NETTER-1 data at ESMO demonstrating significant improvement in PFS regardless of baseline liver tumor burden Lutathera treatment was associated with a

Architecture - 19.10.2018
"Mediocre tools lead to mediocre thinking"
Architect Bernard Tschumi has donated the archives of his Bridge City project - developed for the City of Lausanne in 1988 - to EPFL.

Astronomy / Space Science - 18.10.2018

Medicine / Pharmacology - Business / Economics - 18.10.2018

Innovation / Technology - Computer Science / Telecom - 17.10.2018
Modifying a virtual environment in just a few clicks
Creating and modifying a virtual reality environment just got a lot easier thanks to software being released today by Imverse, an EPFL spin-off.

Event - Architecture - 17.10.2018

Medicine / Pharmacology - Life Sciences - 16.10.2018
Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx leadership in spondyloarthritis
Data from the MEASURE 1 and FUTURE 1 studies show rapid and long-lasting sustained improvement in the signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) ,   In rheumatolo

Physics / Materials Science - Business / Economics - 11.10.2018
Joint research on Laser Deposition Welding
Joint research on Laser Deposition Welding
Empa and BeAM, a manufacturer of machines for metal 3D printing, are glad to announce an extensive research and development agreement.

Environment - 11.10.2018
Scientists head to Antarctica to study snow and icecaps
Scientists head to Antarctica to study snow and icecaps
EPFL scientists will soon be heading off to Antarctica, where they will spend four months collecting reams of meteorological data at Australia's Davis research station.

Medicine / Pharmacology - Life Sciences - 10.10.2018
Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya over Copaxone in patients with relapsing remitting multiple sclerosis
Topline findings from ASSESS show adult relapsing remitting multiple sclerosis (RRMS) patients taking Gilenya (fingolimod) 0.5mg experienced significantly fewer relapses than patients on Copaxone (glatiramer acetate) 20mg   Gilenya 0.5mg is the first and only disease modifying therapy to show superiority in reducing relapses vs Copaxone in a controlled, head-to-head trial   Treatment discontinuations were overall more common in the

Computer Science / Telecom - Innovation / Technology - 10.10.2018

Medicine / Pharmacology - 09.10.2018
Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study
Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study Data published in the American Journal of Hematology show more than twice as many patients taking crizanlizumab did not experience a disease-related pain crisis (also called vaso-occlusive crisis, or VOC) vs placebo   VOCs are the most common, painful complication of sickle cell disease and the main reas

Computer Science / Telecom - Innovation / Technology - 08.10.2018

Event - Careers / Employment - 08.10.2018

Innovation / Technology - 08.10.2018
Summit in the field of Additive Manufacturing
Empa underscores its leading role in the exchange of knowledge in the field of Additive Manufacturing (AM).

Medicine / Pharmacology - Life Sciences - 08.10.2018
Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients
There is a critical need for safe and effective treatments for secondary progressive multiple sclerosis (SPMS) - a highly debilitating form of MS characterized by gradual, irreversible worsening of d

Computer Science / Telecom - 08.10.2018

Innovation / Technology - Careers / Employment - 06.10.2018

Business / Economics - 04.10.2018
Even Small Gifts Boost Business
The offering of a gift - a sign of gratitude for a good business relationship, or a bribe? It's a fine line that is often hard to judge.

Medicine / Pharmacology - Innovation / Technology - 04.10.2018
Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges
Despite major advances in modern medicine, universal access to healthcare remains the largest unmet medical need Building on the inaugural Sandoz HACk, this year's competition expands to seek broader

Medicine / Pharmacology - Life Sciences - 03.10.2018
Roche announces new data for risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress
Roche announces new data for risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress Preliminary findings from Part 1 of the FIREFISH study show that infants with Type 1 SMA are meeting developmental milestones including sitting without support Preliminary data from Part 1 of the SUNFISH study show improvements in motor function in people with Type 2/3 SMA No drug-related safety findings leading to withdrawal in risdiplam

Earth Sciences - Social Sciences - 03.10.2018
Jacques Lévy wins the 2018 Vautrin-Lud Prize
Jacques Lévy wins the 2018 Vautrin-Lud Prize
Jacques Lévy has been awarded the 2018 Vautrin-Lud Prize, a geography award modeled on the Nobel Prize.

Medicine / Pharmacology - 03.10.2018
Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals
Clinical and pre-clinical stage programs focused on addressing growing need for new treatments against drug resistant Gram-negative bacteria   Agreement is part of Novartis strategy to partner with l

Innovation / Technology - Electroengineering - 02.10.2018
Cooperation in printed electronics
Cooperation in printed electronics
Empa is expanding its Coating Competence Center (CCC) thanks to a new partnership in the field of printed electronics with US-based equipment manufacturer Optomec.

Astronomy / Space Science - Chemistry - 28.09.2018
Two Years after Rosetta
Two Years after Rosetta
On September 30, 2016, the active phase of the ESA's Rosetta mission came to an end with the controlled crash landing of the probe on the surface of the comet Chury.

Life Sciences - 27.09.2018
Fructose metabolism and noncommunicable diseases: recent findings and new research perspectives
Prof. Luc Tappy, Department of Physiology Fructose is a physiological nutrient which, when consumed in excess, may have adverse metabolic effects, mainly in the liver (hepatic insulin resistance and fat storage).

Medicine / Pharmacology - 27.09.2018
French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES
Tappy L., Morio B., Azzout-Marniche D., Champ M., Gerber M., Houdart S., Mas E., Rizkalla S., Slama G., Mariotti F., Margaritis I..

Innovation / Technology - 27.09.2018
Naturally against pesticides
Naturally against pesticides
The use of pesticides is still widespread in Swiss agriculture - and the resulting damage to humans and the environment is immense.

Transport - 26.09.2018
Smart transportation systems need smart governance
Two EPFL researchers have just published a book highlighting the need for cities to adopt adequate governance mechanisms for their transportation systems.
1 2 3 4 5 7 Next »